Screener
Viking Therapeutics VKTX Q2 2026 earnings
Reported July 29, 2026 · After market close
EPS-$1.10Beat by $0.13
EPS estimate-$1.23
Next report
Oct 28, 2026 (in a month)EPS estimate-$1.07
Versus estimates
Diluted EPS
FAQ
- When did Viking Therapeutics report Q2 2026 earnings?
- Viking Therapeutics (VKTX) reported Q2 2026 earnings on July 29, 2026 after market close.
- What were Viking Therapeutics's Q2 2026 revenue and EPS?
- Viking Therapeutics reported eps of $-1.10 for Q2 2026.
- Did Viking Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-1.23 by $0.13.
- How did Viking Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 89.7% from $-0.58.
- Where can I find Viking Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-323652) and the 10-Q periodic report (0001193125-26-324219) directly on SEC EDGAR. The filing index links above go to sec.gov.
